Merck KGaA (OTCMKTS:MKKGY) Sees Significant Decline in Short Interest

Merck KGaA (OTCMKTS:MKKGY) saw a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 1,600 shares, a decrease of 97.2% from the November 15th total of 56,900 shares. Based on an average daily trading volume, of 245,500 shares, the short-interest ratio is currently 0.0 days.

Merck KGaA Stock Down 0.8 %

Shares of MKKGY stock traded down $0.24 during mid-day trading on Friday, reaching $29.51. 159,143 shares of the company were exchanged, compared to its average volume of 72,295. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33. The business’s 50 day simple moving average is $32.01 and its 200 day simple moving average is $34.48. The company has a market capitalization of $19.07 billion, a P/E ratio of 18.22, a P/E/G ratio of 2.37 and a beta of 0.93. Merck KGaA has a fifty-two week low of $28.96 and a fifty-two week high of $39.17.

Analyst Ratings Changes

Separately, The Goldman Sachs Group began coverage on Merck KGaA in a research note on Thursday, September 19th. They set a “buy” rating for the company.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.